Parabilis Medicines, Inc.
PBLSNASDAQ
USReal-Time Price
USReal-Time Price$25.35USD
+2.60 (+11.43%)Today
$25.44+0.09 (+0.36%)After Hours7:51 PM ET
BTI Score
Near Future
41
Long Term
38
BTI Fair Market Cap
$1.21B
+155.40% vs fair
Biotechnology
High Risk
Parabilis Medicines, Inc. (PBLS) Stock Overview
Parabilis Medicines, Inc. (PBLS) is a Healthcare company in the Biotechnology industry listed on NASDAQ. Review available quotes, BTI valuation, financial statements, earnings, news and risk information.
Market Cap
$3.09B
Enterprise Value
$2.05B
Volume
2.14M
Avg. Volume
814.00K
P/E (TTM)
-0.69
Forward P/E
N/M
EPS (TTM)
$-62.56
Profit Margin
-66066.89%
FCF Margin
-80500.68%
Dividend Yield
0.00%
Beta
5.03
52 Week Range
$20.00$42.49
Next Earnings
2026-11-12
Time TBD
Investor Snapshot
Analyst Consensus
Strong Buy
Based on 11 analysts
🟢 Buy 10
🟡 Hold 1
🔴 Sell 2
Average Price Target
$41.75
+64.69% Upside
High $45.00Low $40.00
Expected Upside
+64.69%
From current price
Valuation Status
Fair Value
Justified
UndervaluedOvervalued
Risk Level
Moderate
PBLS Price Chart
Trend:Momentum:Volatility:Volume:
Analyst Insights
Strong Buy
Based on 11 analysts
Buy10
Hold1
Sell2
Earnings Trends
Earnings Per Share
↗
Revenue Beat Rate
100%
Beat Rate
Beat1
Meet0
Miss0
Total1
↗
EPS Beat Rate
0%
Beat Rate
Beat0
Meet0
Miss1
Total1
★
Analyst Expectations
77%
Positive
Above10
In-Line1
Below2
Total13
Quarterly EPS Performance
Recent results and upcoming quarterQ2 FY26
30 / 06 / 2026
Estimate$0.08Actual$-2.12Surprise$-2.20 (-2698.04%)
Q3 FY26
30 / 09 / 2026
Estimate—Actual—Surprise—
Q4 FY26
12 / 11 / 2026
Estimate$-0.36Actual—Surprise—
Quarterly Revenue Performance
Actual quarterly revenue with consensus when availableQ2 FY25
30 / 06 / 2025
Estimate—Actual$0Surprise—
Q1 FY26
31 / 03 / 2026
Estimate—Actual$0Surprise—
Q2 FY26
30 / 06 / 2026
Estimate—Actual$150,000Surprise—
Q4 FY26
12 / 11 / 2026
Estimate$333,333Actual—Surprise—
Revenue vs Earnings Over Time
Revenue (B USD)Net Income (B USD)Profit Margin (%)
Source: Yahoo Finance quarterly financialsYoY comparison
PBLS upcoming earnings call
2026-11-12 at 4:30 PM EST
Coming SoonTime TBD
Earnings Call Hub
Listen live or replay earnings calls with AI-powered insights.
Coming SoonTime TBD
PBLS upcoming earnings call
2026-11-12
Reminder via
AI Call Summary
BetaPBLS is expected to report results shaped by demand trends, margin performance and management guidance. Investors should watch earnings quality, cash flow and outlook commentary.
Call Agenda
Revenue Review
Guidance & Outlook
Data Center Update
HBM Growth
NAND Market
Q&A Session
Recent News
Company Overview
CEO
Mathai Mammen
Founded
2026
Employees
145
Headquarters
Cambridge, MA
Industry
Biotechnology
Website
Top Gainers
IRON
Disc Medicine, Inc.
$78.93
+38.86%
CLF
Cleveland-Cliffs Inc.
$14.10
+16.34%
MANE
Veradermics, Incorporated
$122.28
+12.37%
AGIO
Agios Pharmaceuticals, Inc.
$34.90
+11.43%
PBLS
Parabilis Medicines, Inc.
$25.35
+11.43%
ARQT
Arcutis Biotherapeutics, Inc.
$31.89
+10.65%
AXTI
AXT Inc
$56.79
+10.34%
VRDN
Viridian Therapeutics, Inc.
$20.80
+9.30%
Top Losers
Upcoming Earnings
ASX
ASE Technology Holding Co., Ltd. American Depositary Shares (each representing Two Common Shares)
2026-10-29
-
Analyst Insights
Strong Buy
Based on 11 analysts
Buy10
Hold1
Sell2
People Also Watch
PBLS Earnings Call Reminder
PBLS upcoming earnings call
2026-11-12
Time TBD